Search Results - "Barlier, Anne"
-
1
-
2
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
Published in Clinical cancer research (01-02-2020)“…Aggressive meningiomas that progress after surgery/radiotherapy represent an unmet medical need. Strong and constant expression of SSTR2A receptors and…”
Get full text
Journal Article -
3
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
Published in Journal of neurosurgery (01-09-2017)“…OBJECTIVE Meningiomas express somatostatin receptor subtype 2 (SST2), which is targeted by the somatostatin analog octreotide. However, to date, using…”
Get full text
Journal Article -
4
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
Published in European journal of endocrinology (01-12-2016)“…Objective Disorders caused by impairments in the parathyroid hormone (PTH) signalling pathway are historically classified under the term…”
Get full text
Journal Article -
5
Prospective comparison of Ga-68-DOTATATE and F-18-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases
Published in European journal of nuclear medicine and molecular imaging (01-07-2016)“…Purpose Pheochromocytomas/paragangliomas (PHEOs/PGLs) overexpress ă somatostatin receptors and recent studies have already shown excellent ă results in the…”
Get full text
Journal Article -
6
IGSF1 mutations are the most frequent genetic aetiology of thyrotropin deficiency
Published in European journal of endocrinology (01-12-2022)“…Design Thyroid-stimulating hormone deficiency (TSHD) is a rare disease. It may be isolated, secondary to abnormalities of genes involved in TSH biosynthesis,…”
Get full text
Journal Article -
7
Role of the tumor microenvironment in digestive neuroendocrine tumors
Published in Endocrine-related cancer (01-11-2018)“…Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a group of heterogeneous tumors whose incidence increased over the past few years. Around…”
Get full text
Journal Article -
8
Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism
Published in The journal of clinical endocrinology and metabolism (01-10-2022)“…Abstract Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by inactivating mutations in the MEN1 gene. In the…”
Get full text
Journal Article -
9
Hypoxia and the hypoxia inducible factor 1α activate protein kinase A by repressing RII beta subunit transcription
Published in Oncogene (16-04-2020)“…Overactivation of the cAMP signal transduction pathway plays a central role in the pathogenesis of endocrine tumors. Genetic aberrations leading to increased…”
Get full text
Journal Article -
10
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
Published in Acta neuropathologica (01-12-2010)“…The phenotypic heterogeneity of low-grade gliomas (LGGs) is still inconsistently explained by known molecular abnormalities in patients treated according to…”
Get full text
Journal Article -
11
Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism
Published in Pediatrics (Evanston) (01-04-2015)“…Pseudohypoparathyroidism (PHP) is a group of disorders characterized by end-organ resistance to the parathyroid hormone (PTH). PHP type 1A includes…”
Get full text
Journal Article -
12
Editorial: New insights into multiple endocrine neoplasia type 1
Published in Frontiers in endocrinology (Lausanne) (11-08-2023)Get full text
Journal Article -
13
MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives
Published in Endocrine (01-09-2020)“…Multiple endocrine neoplasia type 2 (MEN2) is a rare hereditary syndrome due to mutations of the proto-oncogene REarranged during Transfection (RET), defined…”
Get full text
Journal Article -
14
Challenges in molecular diagnosis of multiple endocrine neoplasia
Published in Frontiers in endocrinology (Lausanne) (27-09-2024)“…Multiple endocrine neoplasia (MEN) is a group of rare genetic diseases characterized by the occurrence of multiple tumors of the endocrine system in the same…”
Get full text
Journal Article -
15
Germinal defects of SDHx genes in patients with isolated pituitary adenoma
Published in European journal of endocrinology (01-10-2020)“…Background: The ‘3PAs’ syndrome, associating pituitary adenoma (PA) and pheochromocytoma/paraganglioma (PPGL), is sometimes associated with mutations in…”
Get full text
Journal Article -
16
Somatotroph Tumors and the Epigenetic Status of the GNAS Locus
Published in International journal of molecular sciences (15-07-2021)“…Forty percent of somatotroph tumors harbor recurrent activating GNAS mutations, historically called the gsp oncogene. In gsp-negative somatotroph tumors, GNAS…”
Get full text
Journal Article -
17
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population
Published in The journal of clinical endocrinology and metabolism (01-03-2019)“…Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the MEN1 gene characterized by a broad spectrum of clinical…”
Get full text
Journal Article -
18
Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications
Published in Journal of mammary gland biology and neoplasia (01-01-2015)“…Abstract Succinate dehydrogenase gene (SDHx) mutations increase susceptibility to develop pheochromocytomas/paragangliomas (PHEOs/PGLs). In the present study,…”
Get full text
Journal Article -
19
Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome
Published in The Journal of pediatrics (01-02-2019)“…The GNAS postzygotic mosaic activating mutations involved in fibrous dysplasia and McCune-Albright syndrome (MAS) are not detectable in leukocytes by Sanger…”
Get full text
Journal Article -
20
Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms
Published in Endocrine-related cancer (01-02-2018)“…Over the last years, the knowledge of MEN2 and non-MEN2 familial forms of pheochromocytoma (PHEO) has increased. In MEN2, PHEO is the second most frequent…”
Get full text
Journal Article